KALV
KalVista Pharmaceuticals Inc.
$13.46
-$0.05(-0.37%)
37
Overall
--
Value
36
Tech
39
Quality
Market Cap
$657.39M
Volume
436.47K
52W Range
$7.30 - $16.32
Target Price
$31.67
Key Metrics Overview
| Market Cap | $657.39M | P/E Ratio | N/A |
| 52W High | $16.32 | 52W Low | $7.30 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -2.4% | 52W Position | 68.3% |
| Overall Score | 37 | Value Score | -- |
| Quality Score | 39 | Technical Score | 36 |
Growth Analysis
| EPS Current Est | $-3.31 | EPS Next Est | $-1.84 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KALV | $13.46 | -0.4% | 436.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get KalVista Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW